Accordingly, the powerful ability of FoxM1 inhibition in resistant cancer cells to induce apoptosis in response to Artemisinin therapy points towards its encouraging therapeutic potential during cancer progression (Supplementary Figure 5). This evidence concerns the gene FOXM1 and cancer.